Covid-19 Impact on Drug Screening Market is Expected to Grow at an Impressive CAGR by 2028

This strategic assessment report provides a comprehensive analysis that reflects today’s Drug Screening Market realities and future possibilities for the forecast period of 2022 to 2028.

Stratview Research announces the launch of a new research report on the Drug Screening Market is Segmented by Product & Services (Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Services), by Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other), by End User (Workplace, Criminal Justice Systems, and Law Enforcement Agencies, Drug Treatment Centers, Pain Management Centers, Drug Testing Laboratories, Others), and Region.

Report Features

The report delivers a detailed view of the industry based on global Drug Screening Market size, market growth, and opportunities. The report also analyses market key aspects such as-

• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Covid-19 Impact analysis.
• Market environment analysis: Growth drivers and constraints, and SWOT analysis.
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players

Highlights from the Report

The drug screening market was estimated at USD 5.24 billion in 2021 and is likely to grow at a CAGR of 16.74% during 2022-2028 to reach USD 15.52 billion in 2028.

What is drug screening?

Drug screening is defined as the process of collecting and analyzing blood, hair, urine, or saliva to detect the presence of contaminants and chemicals left in the body as a result of drug consumption. In this process, potential drugs are identified and optimized before selecting a candidate drug for a clinical trial. Drug screening is done in order to determine if a person is or has consumed drugs at a certain point in time.

According to the report, the key players in the market are –

• Alere Inc. (The U.S),
• Laboratory Corporation of America Holdings (The U.S),
• OraSure Technologies (The U.S),
• Quest Diagnostics (The U.S),
• Thermo Fisher Scientific (The U.S),
• Alfa Scientific Designs, Inc. (The U.S),
• MPD Inc. (The U.S),
• Lifeloc Technologies, Inc. (The U.S),
• Omega Laboratories Inc. (The U.S),
• Sciteck Diagnostics Inc (The U.S),
• ACM GLOBAL LABORATORIES (The U.S), and
• Carehealth America Corporation (The U.S).

Customization of the Report:

Stratview Research also provides customised reports to meet the client’s requirements. Please connect with our sales team (E-mail: sales@stratviewresearch.com) to get a customised report that suits your needs. You can also get in touch with our executives on +1-313-307-4176 to share your research requirements.

Know more about us and our reports here –

Stratview Research publishes high quality, in-depth market research studies, to help clients obtain grainy level clarity on present business trends and probable future developments. At Stratview Research, we are committed to our client’s needs, providing custom solutions best fit for strategy development and implementation to extract perceptible results. We have built our team around this belief, with industry analysts, consultants and domain experts, leveraging their global experience, helping us deliver excellence in all assignments we undertake.

Article source: https://article-realm.com/article/Business/Careers/42708-Covid-19-Impact-on-Drug-Screening-Market-is-Expected-to-Grow-at-an-Impressive-CAGR-by-2028.html